Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy.
Overview
publication date
- August 18, 2021
published in
- JAAD case reports Journal
Identity
PubMed Central ID
- PMC8413661
Scopus Document Identifier
- 85122699646
Digital Object Identifier (DOI)
- 10.1016/j.jdcr.2021.08.005
PubMed ID
- 34504927
Additional Document Info
has global citation frequency
volume
- 16